贝伐珠单抗联合XELOX化疗治疗结直肠癌患者的效果及对其血清CRP水平的影响

PDF(914 KB)

包头医学院学报 ›› 2022, Vol. 38 ›› Issue (9) : 36-39. DOI: 10.16833/j.cnki.jbmc.2022.09.008

作者信息 +

The effect of bevacizumab combined with XELOX chemotherapy in the treatment of patients with colorectal cancer and its effect on serum CRP levels

Author information +

文章历史 +

导出引用

{{article.zuoZheCn_L}}. {{article.title_cn}}[J]. {{journal.qiKanMingCheng_CN}}, 2022, 38(9): 36-39 https://doi.org/10.16833/j.cnki.jbmc.2022.09.008

{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2022, 38(9): 36-39 https://doi.org/10.16833/j.cnki.jbmc.2022.09.008

中图分类号：

原文顺序 | 文献年度倒序 | 文中引用次数倒序

PDF(914 KB)

Accesses

Citation

Detail

段落导航